In order to deduce the predominant haplotypes in Japanese narcoleptics, we have studied a total of 111 Japanese patients with narcolepsy and six multiple-case families for HLA class I and class II antigens, and for class III HLA-linked complement markers. In Japanese narcoleptics, the most frequent haplotypes were B35-DR2, B15-DR2, and B51-DR2. These haplotypes were rare in normal Japanese population. In contrast, the most frequent haplotype of HLA-DR2 in normal Japanese, A24-C blankBw52-C4A*2 B*QO-BF *S-C2*C-DR2-DQwl, had a decreased frequency to one-third of the normal controls. Haplotypes B35-DR2, B15-DR2, and B51-DR2, which were more frequent among Japanese narcoleptics, were different from the haplotype found more frequently among Caucasoid narcoleptics, A3-Cw7-B7-DR2-DQwl. Haplotype analysis on six families showed that B35-DR2 and other rare haplotypes in normal Japanese were associated with narcolepsy. There were four cases without any signs of narcolepsy among 19 subjects with the disease susceptibility haplotypes. This finding suggests an incomplete penetrance of hepersomnia. Haplotype analysis of family members was also useful for the early detection of the high risk children to narcolepsy.
Introduction
Narcolepsy is a sleep disorder characterized by recurrent napping in the daytime persisting for years (napping habit), irresistible attacks of sleep (sleep attacks), and sudden loss of tone in the striated muscles which typically occurs at moments of increased emotion (cataplexy). Other characteristics of narcolepsy are sleep paralysis, which is often accompanied by vivid and frightening hallucinations, and a rapid eye movement period at the onset of sleep.
The precise etiology of narcolepsy is unknown. It appears certain, however, that genetic factors play a role in the pathogenesis of the disease (1-3). But only a few studies have been carried out regarding the relationship ofvarious genetic markers and narcolepsy (4, 5) .
Regarding the research on this relationship, we were the first to describe a strong association between HLA-DR2 and narcolepsy (6) (7) (8) . HLA-DR2 was found positive in 100% of more than 40 Japanese narcoleptic patients (6) (7) (8) , and in -65% of Receivedfor publication 20 May 1985. patients with excessive daytime sleepiness (6, 7) . We also observed a significant increase in frequency of HLA-B35 and a significant decrease in frequency of Bw52 and B7 (5) (6) (7) (8) . A preliminary study on families with a narcolepsy proband showed a close association between HLA-DR2 and the disease (7) . After our studies, other investigators reported that all the 37 English (9) and eight French (10) patients with narcolepsy were HLA-DR2 positive. These reports confirmed that a strong association between HLA-DR2 and the disease was also present in the Caucasoid population.
On the other hand, differences in HLA class I allele frequencies were observed between Japanese and Caucasoid patients. The frequency ofHLA-B7 increased in Caucasoid patients (9, 1 1) while it decreased in Japanese patients (5) (6) (7) (8) . HLA-A2 increased in Japanese patients (8, 12) while HLA-A3 increased in Caucasoid narcoleptics (9) . These data indicated that different haplotypes might be associated with narcolepsy in Japanese and Caucasoid patients.
In the present report, we extended the number of patients to 111, and analyzed haplotype and gene frequencies statistically. HLA-linked complement markers were determined for the first time for narcoleptic patients. Family studies were also performed on six multiple-case families. Frequent haplotypes in Japanese narcoleptics were considered to be different from the frequent haplotypes found in Caucasoid patients and those commonly found in the normal Japanese.
Methods
I I I outpatients with narcolepsy at the Department of Neuropsychiatry, Tokyo University Hospital (64 males and 47 females, between 16 and 74 yr of age), and 308 apparently healthy Japanese were studied. All the cases with narcolepsy that had been typed for HLA antigens between March 1983 and December 1984 were included in this study. Previously reported cases (5) (6) (7) (8) 12 ) were also included. Complement allotypes were determined for the patients who had been tissue-typed between October 1983 and July 1984.
Our diagnostic criteria of narcolepsy are as follows: (a) recurrent daytime naps, occurring almost every day and persisting for at least six months; (b) clinical confirmation of cataplexy in the patient's history, concurrent with a. Both a and b must be present. Our criteria of narcolepsy' has been discussed elsewhere (1) .
Serological HLA typing was performed by a standard microcytotoxity 1 . In this paper, the terms "essential hypersomnia" and "excessive daytime somnolence" were also used. Essential hypersomnia is defined by the following criteria: (a) recurrent daytime naps, occurring almost every day and persisting for at least 6 mo; (b) absence of cataplexy; (c) not due to other known disorders associated with daytime somnolence, such as sleep-apnea syndrome. Excessive daytime sleepiness is used to denote morbid somnolence with and without episodes ofcataplexy on the basis of information obtained from family members. Workshop (19) . Data in our previous reports were used as complement C2 and BF controls (13, 14) . Chi-square test or Fisher's exact test was used to determine the statistical significance of comparative phenotype frequencies. Differences in haplotype frequencies were tested as described by Cavalli-Sforza and Bodmer (20).
Results
Phenotype and genefrequencies ofHLA class I and class II antigens in 111 Japanese patients with narcolepsy. The phenotype and the estimated gene frequencies of HLA alleles are shown in Table II . All ofthe 11 1 patients with narcolepsy were HLA-DR2 positive (significantly increased in frequency at corrected P < 10-29). The relative risk for DR2 was 436. The numbers of HLA-DR2 homozygotes and heterozygotes were 29 and 82, respectively. The phenotype frequency of DQwl was also 100% in the narcoleptics (corrected P < 10-12). The frequencies of other DR alleles, DR1, DRw8, DRw9, and DRw13, were significantly decreased. The frequencies of "supertypic" antigens, DRw52 and DRw53, which do not usually associate with DR2, were also significantly decreased.
As for class I alleles, the frequencies of B35 and Bw67 were significantly increased in the patient group. The frequency of Bw52 decreased to about a third of that in the normal controls. The frequency of B7 also decreased significantly. A significant increase in A2 and Cw3 frequencies was also observed.
HLA-linked complement markers. The frequency of C2*C decreased and that ofC2*AT increased in the narcoleptic patients (Table III) . The increase in BF*F frequency and the decrease in BF*S frequency were significant. The frequency of C4A*2 decreased, while that of C4B*2 and C4A rare alleles increased.
The estimated frequency of C4A*2 B*QO was nearly one-third of the normal value (P < 0.005, Table IV ). Estimated frequencies of two-and three-locus haplotypes. Table V gives the estimated frequencies and the standard errors offrequent two-locus haplotypes among the narcoleptic patients and those ofthe corresponding haplotypes in the normal subjects. Three haplotypes, B35-DR2, BI 5-DR2, and B5 I-DR2, which are rare in the Japanese (19, 21) , were significantly increased in frequency among the narcoleptic patients. On the other hand, Bw52-DR2, which is one ofthe most frequent haplotypes among normal Japanese, decreased in frequency to about one-third of the normal controls in the narcoleptics (0.1 < P < 0.2). Table VI shows the frequent three-locus haplotypes in the Japanese narcoleptic patients. Haplotype A2-B35-DR2 was the most frequent, while haplotype A24-Bw52-DR2 decreased in frequency to about one-third of the controls.
HLA haplotype in six multiple-case families. Figs. 1 and 2 depict six multiple-case families and their deduced haplotypes. In family NS, all the family members with narcolepsy or excessive daytime sleepiness had the "a" haplotype, A3 1-Cw3-B35-C4A*4 B*2-C2*C-BF *F-DR2-DQw1. In family SK, the "a" haplotype, A24-C blank-Bw52-C4A* 1 3J B*Q0-C2*C-BF *S-DR2-DQwl, was associated with narcolepsy where C4A 13J is a tentative In family AK, two family members with the "a" haplotype, A2-Cw l-Bw54-DR2-DQwl, had narcolepsy. The second child of the proband (III 6, 15 yr old) had the "a" haplotype. In his case, he had not been seriously aware of his somnolence before being interviewed for this study. He used to nap in the classroom over the past year, could not concentrate on studying, and his grades recently dropped. He attributed this to his devotion to baseball practice. In his case, no cataplexy, hypnagogic hallucinations, or sleep paralysis were confirmed. A polysomnogram of this patient showed a rapid eye movement period within 10 min from the onset of sleep, and a marked tendency to fall asleep. He is now under medication with pemoline, and is successfully attending college without daytime somnolence. In this family, four family members with the "a" haplotype had excessive somnolence, while the first child (III 3) of the proband's sister with the "a" haplotype did not show any signs of narcolepsy.
In family NJ, the proband (III 1) and her relative (IV 2) had the same "a" haplotype, A26-Cw3-B35-DR2-DQwl. In this case, the mother (111 6) of the relative also had the "a" haplotype, but did not show any signs of excessive somnolence. In family HG, the "a" haplotype, Al I-Cw7-Bw67-DR2-DQw1, was associated with narcolepsy and essential hypersomnia. In these families, three out of six "a" haplotypes associated with narcolepsy were B35-Cw3-DR2-DQwI.
Discussion
The present study shows that certain rare haplotypes increased statistically among Japanese narcoleptic patients. These rare haplotypes with increased frequency were B35-DR2, BI 5-DR2, and B5 I-DR2. Also, three-locus haplotypes, A2-B35-DR2, A24-B35-DR2, A24-B51-DR2, A2-B51-DR2, and A2-B1 5-DR2 had increased in frequency. These haplotypes were uncommon among the healthy Japanese population (19, 21) .
On the other hand, the frequencies of HLA-Bw52, Bw52-DR2, A24-Bw52-DR2, and a complement C4 haplotype A*2 B*QO had decreased to about one-third of the frequency in normal Japanese. These data indicate a decrease in the narcoleptics of the most common haplotype of HLA-DR2 found in normal Japanese, A24-C blank-Bw52-C4A*2 B*Q0-BF *S-C2*C-Dw12-DR2-DQwl (19, 21) . The decrease of C2*C and BF*S frequencies was less evident because they are also linked with other haplotypes (22) . Similar differential changes in haplotype frequencies were observed in ankylosing spondylitis. Terasaki and Mickey (23) computed haplotype frequencies from the data of patients with ankylosing spondylitis, and found that the frequencies of Al-B27 and A3-B27 were lower, while that of A30-B27 was higher than expected from the controls. If HLA-B27 itself were a disease susceptibility gene, haplotype frequencies of HLA-B27 should have raised equally. They speculated that a disease susceptibility gene to ankylosing spondylitis was not HLA-B27 itself but a gene(s) other than HLA-B27, linked to the "diseased" haplotype.
In narcolepsy the situation is more complicated, since HLA-DR2 may split into more than one specificity (24) . Increased haplotypes in narcolepsy may bear a split antigen(s) of HLA-DR2 different from that of the common haplotypes, and that split antigen(s) may associate with narcolepsy. Similarly, possible split antigens of HLA-DQwl have been proposed (25, 26). We must first consider possible differences between the rare increased haplotypes and the common decreased haplotype.
One possibility is that HLA-D alleles were different between these haplotypes. HLA-D specificity in strong linkage disequilibrium with haplotype A24-C blank-Bw52-DR2, the most common haplotype in the normal Japanese, is HLA-Dw12 (27). Since the frequency of haplotype had significantly decreased, we can assume that HLA-Dw12 possibly decreased. Several other cytologically determined specificities have been known to associate with HLA-DR2, including Dw2, FJO, DB9, and MN2 (24) . Except for the haplotype HLA A24-C blank-Bw52-DR2 and HLA-Dwl2, no data has been available as to which haplotype associates with which HLA-D specificity in the Japanese. The rare haplotypes may carry HLA-Dw2, as would be the case in Caucasoid patients, but this should be substantiated.
Another possibility is that DQ alleles are different. Recent studies have shown that DQ genes have a higher level of polymorphism than is currently recognized by serological methods (28, 29) . Restriction fragment length polymorphism has been demonstrated within the same DQwl and DR2 specificities (28, 29). Since DQwl has also been found 100% positive in narcoleptics, a primary disease susceptibility factor could be DQ allele.
It is also possible that there is-no difference in HLA-DR or DQ alleles for the rare and common haplotypes. If there is no difference, the presence of a disease susceptibility gene(s) itself on the rare haplotypes would be the only distinguishing feature. Further studies are needed to clarify the key differences between the rare and common haplotypes.
Among Caucasoid narcoleptics, A3, B7, Cw7, DR2, and DQwl had increased in frequency (9-11). A3-Cw7-B7-DR2-DQwl is one of the most frequent haplotypes among Caucasoids, and it usually associates with HLA-Dw2. In our research on Japanese narcoleptics, there was no evidence to indicate an increase of this haplotype. This ethnic difference in haplotype frequencies seems to be the cause of the difference in HLA class I antigen frequencies between Japanese and Caucasoid narcoleptic patients.
Our results show that only heterozygous expression of HLA-DR2 was sufficient for the development of narcolepsy. The ratio of HLA-DR2 homozygotes to heterozygotes is explained by assuming a dominant inheritance model of a putative disease susceptibility gene linked to HLA-DR2 (Table VII) . A recessive model can be ruled out at P < 10-28 (chi square = 126). This dominant inheritance model regarding HLA-DR2 was also reported to be applicable in cases of Caucasoid narcolepsy (9).
Our study on six multiple-case families shows that all the patients with somnolent disorders were HLA-DR2 positive, and family members who were HLA-DR2 negative never developed 19 subjects had disease susceptibility haplotypes. Among them, eight subjects were suffering from narcolepsy, three from essential hypersomnia, four from excessive daytime sleepiness, and four had no symptoms of excessive daytime somnolence. This data shows that there were subjects who did not develop narcolepsy even ifthey had a disease susceptibility HLA haplotype. This incomplete penetrance of the disease and the multiform appearance of both narcolepsy and essential hypersomnia suggest that factors other than a HLA-DR2-linked disease susceptibility gene(s) are also required for the full manifestation of narcolepsy. This finding agrees with a two-threshold multifactorial inheritance model previously proposed by many investigators (1, 3) . In some cases, environmental factors seem to play a precipitating role in the development of narcolepsy.
In family AK, haplotype analysis was useful to detect a family member at risk of narcolepsy. A subject without HLA-DR2 seems completely free from narcolepsy, but a subject with HLA-DR2 has a certain possibility to develop it (5, 6) . Haplotype analysis of the family members is useful for the early detection of the high risk children to narcolepsy, and also for the possible prevention of the development of narcolepsy by avoiding precipitating environmental factors that may contribute to the development of the disease.
